166 related articles for article (PubMed ID: 16425381)
1. Expression of Ki-67, p53, and K-ras in chronic pancreatitis and pancreatic ductal adenocarcinoma.
Jeong S; Lee DH; Lee JI; Lee JW; Kwon KS; Kim PS; Kim HG; Shin YW; Kim YS; Kim YB
World J Gastroenterol; 2005 Nov; 11(43):6765-9. PubMed ID: 16425381
[TBL] [Abstract][Full Text] [Related]
2. Ductal lesions in patients with chronic pancreatitis show K-ras mutations in a frequency similar to that in the normal pancreas and lack nuclear immunoreactivity for p53.
Lüttges J; Diederichs A; Menke MA; Vogel I; Kremer B; Klöppel G
Cancer; 2000 Jun; 88(11):2495-504. PubMed ID: 10861425
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical evaluation of K-ras, p53, and HER-2/neu expression in hyperplastic, dysplastic, and carcinomatous lesions of the pancreas: evidence for multistep carcinogenesis.
Apple SK; Hecht JR; Lewin DN; Jahromi SA; Grody WW; Nieberg RK
Hum Pathol; 1999 Feb; 30(2):123-9. PubMed ID: 10029438
[TBL] [Abstract][Full Text] [Related]
4. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia.
Caldas C; Hahn SA; Hruban RH; Redston MS; Yeo CJ; Kern SE
Cancer Res; 1994 Jul; 54(13):3568-73. PubMed ID: 8012983
[TBL] [Abstract][Full Text] [Related]
5. [Morphologic, morphometric and immunohistochemical studies on pancreatic intraductal hyperplasia and infiltrating carcinoma].
Tomaszewska R
Folia Med Cracov; 1999; 40(1-2):101-41. PubMed ID: 10909469
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic intraepithelial neoplasia in heterotopic pancreas: evidence for the progression model of pancreatic ductal adenocarcinoma.
Zhang L; Sanderson SO; Lloyd RV; Smyrk TC
Am J Surg Pathol; 2007 Aug; 31(8):1191-5. PubMed ID: 17667542
[TBL] [Abstract][Full Text] [Related]
7. Ki-ras codon 12 point mutation and p53 mutation in pancreatic diseases.
Yamaguchi K; Chijiiwa K; Noshiro H; Torata N; Kinoshita M; Tanaka M
Hepatogastroenterology; 1999; 46(28):2575-81. PubMed ID: 10522044
[TBL] [Abstract][Full Text] [Related]
8. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium.
Lüttges J; Schlehe B; Menke MA; Vogel I; Henne-Bruns D; Klöppel G
Cancer; 1999 Apr; 85(8):1703-10. PubMed ID: 10223563
[TBL] [Abstract][Full Text] [Related]
9. Trefoil factor family peptides in normal and diseased human pancreas.
Guppy NJ; El-Bahrawy ME; Kocher HM; Fritsch K; Qureshi YA; Poulsom R; Jeffery RE; Wright NA; Otto WR; Alison MR
Pancreas; 2012 Aug; 41(6):888-96. PubMed ID: 22286382
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of K-ras point mutation, telomerase activity, and p53 overexpression in pancreatic tumours.
Uemura K; Hiyama E; Murakami Y; Kanehiro T; Ohge H; Sueda T; Yokoyama T
Oncol Rep; 2003; 10(2):277-83. PubMed ID: 12579258
[TBL] [Abstract][Full Text] [Related]
11. Analysis of K-ras oncogene mutations in chronic pancreatitis with ductal hyperplasia.
Rivera JA; Rall CJ; Graeme-Cook F; Fernández-del Castillo C; Shu P; Lakey N; Tepper R; Rattner DW; Warshaw AL; Rustgi AK
Surgery; 1997 Jan; 121(1):42-9. PubMed ID: 9001550
[TBL] [Abstract][Full Text] [Related]
12. Expression and diagnostic evaluation of the human tumor-associated antigen RCAS1 in pancreatic cancer.
Akashi T; Oimomi H; Nishiyama K; Nakashima M; Arita Y; Sumii T; Kimura T; Ito T; Nawata H; Watanabe T
Pancreas; 2003 Jan; 26(1):49-55. PubMed ID: 12499917
[TBL] [Abstract][Full Text] [Related]
13. Differential cell cycle and proliferation marker expression in ductal pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia (PanIN).
Karamitopoulou E; Zlobec I; Tornillo L; Carafa V; Schaffner T; Brunner T; Borner M; Diamantis I; Zimmermann A; Terracciano L
Pathology; 2010 Apr; 42(3):229-34. PubMed ID: 20350215
[TBL] [Abstract][Full Text] [Related]
14. Lack of apoptosis in PanIN-1 and PanIN-2 lesions associated with pancreatic ductal adenocarcinoma is not dependent on K-ras status.
Lüttges J; Neumann S; Jesenofsky R; Borries V; Löhr M; Klöppel G
Pancreas; 2003 Oct; 27(3):e57-62. PubMed ID: 14508142
[TBL] [Abstract][Full Text] [Related]
15. The role of p21ras in pancreatic neoplasia and chronic pancreatitis.
Mulligan NJ; Yang S; Andry C; Klein M; O'Brien MJ
Hum Pathol; 1999 Jun; 30(6):602-10. PubMed ID: 10374765
[TBL] [Abstract][Full Text] [Related]
16. Relationship between K-ras mutation and the expression of p21WAF1/CIP1 and p53 in chronic pancreatitis and pancreatic adenocarcinoma.
Hermanová M; Lukás Z; Kroupová I; Kleibl Z; Novotný J; Nenutil R; Pazourková M; Brázdil J; Kren L; Díte P
Neoplasma; 2003; 50(5):319-25. PubMed ID: 14628083
[TBL] [Abstract][Full Text] [Related]
17. Frequency of K-ras mutations in pancreatic intraductal neoplasias associated with pancreatic ductal adenocarcinoma and chronic pancreatitis: a meta-analysis.
Löhr M; Klöppel G; Maisonneuve P; Lowenfels AB; Lüttges J
Neoplasia; 2005 Jan; 7(1):17-23. PubMed ID: 15720814
[TBL] [Abstract][Full Text] [Related]
18. Sialylated MUC1 mucin expression in normal pancreas, benign pancreatic lesions, and pancreatic ductal adenocarcinoma.
Masaki Y; Oka M; Ogura Y; Ueno T; Nishihara K; Tangoku A; Takahashi M; Yamamoto M; Irimura T
Hepatogastroenterology; 1999; 46(28):2240-5. PubMed ID: 10521973
[TBL] [Abstract][Full Text] [Related]
19. The role of Ras mutation in pancreatic cancer, precancerous lesions, and chronic pancreatitis.
Tabata T; Fujimori T; Maeda S; Yamamoto M; Saitoh Y
Int J Pancreatol; 1993 Dec; 14(3):237-44. PubMed ID: 8113625
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic ductal adenocarcinomas with multiple large cystic structures: a clinicopathologic and immunohistochemical study of seven cases.
Nitta T; Mitsuhashi T; Hatanaka Y; Hirano S; Matsuno Y
Pancreatology; 2013; 13(4):401-8. PubMed ID: 23890139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
